Respiratory Tract Diseases  >>  AZD5423  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5423 / AstraZeneca
NCT01225549: The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen

Completed
2
27
Canada
AZD5423, Budesonide 200 microgram, Pulmicort, Placebo
AstraZeneca
Asthma
12/11
12/11

Download Options